(S)-N-((R)-1-Phenylethyl)quinuclidin-3-amine dihydrochloride, 97%, 250mg

Boc-Tyr-OTbu, 98%, 5g

(E)-METHYL 3-(3-(((4'-(DIMETHYLAMINO)-[1,1'-BIPHENYL]-4-YL)METHYL)AMINO)PHENYL)ACRYLATE, 90.0%, 250mg

3-(Methylthio)thiophene, 97.0%, 1g

6-Bromo-3,4-dihydro-1H-[1,8]naphthyridin-2-one, 95.0%, 25g

3-Hydrazinoquinoxalin-2-ol, 95.0%, 10g

5-Bromo-2-fluoro-3-methyl pyridine, 98.0%, 25g

N-(2-Aminoethyl)-N-methyl carbamic acid tert-butylester, 98.0%, 5g

Z-EDA.HCl, 99.0%, 500g

(R)-2-Aminonon-8-enoic acid hydrochloride, 98.0%, 100mg

2,4,6,8-Tetrachloropyrimido[5,4-d]pyrimidine>98.0%(GC)(N)1g

GC capillary column ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Savolitinib, 99.90%, 5mg